1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 670 F.Supp.2d
  5. 670 F.Supp.2d 359 (2009)
 

DAIICHI SANKYO CO. v. MYLAN PHARMACEUTICALS

Civ. Nos. 06-3462, 07-3039, 08-2752.

670 F.Supp.2d 359 (2009)

DAIICHI SANKYO COMPANY, LIMITED and Daiichi Sankyo, Inc., Plaintiffs and Counterclaim Defendants, v. MYLAN PHARMACEUTICals inc., Mylan Laboratories Inc., Matrix Laboratories, Ltd., and Mylan, Inc., Defendants and Counterclaim Plaintiffs.

United States District Court, D. New Jersey.

July 30, 2009.

Attorney(s) appearing for the Case

William J. Heller, Jonathan M.H. Short, Mark H. Anania, Nicole A. Corona, McCarter & English, LLP, Newark, NJ, for Plaintiffs and Counterclaim Defendants.

Arnold B. Calmann, Jeffrey S. Soos, Katherine Ann Escanlar, Saiber LLC, Newark, NJ, for Defendants and Counterclaim Plaintiffs.

OPINION

MARTINI, District Judge.

Plaintiffs Daiichi Sankyo Company, Limited and Daiichi Sankyo, Inc. (collectively "Daiichi Sankyo") are the inventors and producers of olmesartan medoxomil, the active ingredient in the hypertension medications Benicar, Benicar HCT, and Azor. Defendants Mylan Pharmaceuticals Inc., Mylan Laboratories Inc., Matrix Laboratories, LTD., and Mylan, Inc. (collectively "Mylan") are drug manufacturers seeking to market a generic version...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases